Table 1. Selected IGF-1R inhibitors evaluated in the clinic.
| Drug | Company | Phase of study |
|---|---|---|
| Figitumumab (CP-751, 871) | Pfizer | III |
| R1507 | Roche | II |
| Cixutumumab (IMC-A12) | Imclone | II |
| Dalotuzumab (MK-0646) | Merck | II |
| OSI-906 | OSI pharmaceuticals | I, II |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.